01st February 2022 | Pharma Updates
Infalliable Pharma Plans to Expand its Market
The company has started its operations as a distributor in the critical care segment.
Paolo Doncecchi joins Proteon Pharma as a Global Sales Director
He has more than 30 years of experience in marketing and sales at global biotech companies.
Alkem Labs partners with Johns Hopkins University
Alkem Laboratories has inked a licensing agreement with John Hopkins University for commercializing colorectal cancer treatment.
Japanese pharma company says Ivermectin effective against Omicron in phase 3 trial
The clinical trial found ivermectin has “an antiviral effect” against the Omicron infection, Kowa said without revealing more details.
GI Dynamics Secures Approval of the ISTEP Clinical Study in India
The company will study EndoBarrier® for glycemic improvement in patients with type 2 diabetes and obesity.
Roche bags USFDA approval for Vabysmo
Vabysmo is the fourth FDA-approved drug for “wet” age-related macular degeneration.
Glenmark gets nod for generic MetroGel
The drug is a generic version of Bausch Health US LLC’s MetroGel-Vaginal, which is used for the treatment of bacterial vaginosis.
You must be logged in to post a comment.